Skip to main content
. 2021 Mar 18;2021(3):CD011424. doi: 10.1002/14651858.CD011424.pub3

ACTRN12614000656639.

Study name Pipelle for pregnancy (PIP) in couples with subfertility related to unexplained infertility
Methods Randomised controlled trial
Participants Inclusion criteria:
  • Couples having regular unprotected sexual intercourse in a relationship where pregnancy is desired

  • Women between 18 and 42 years of age at the time of randomisation

  • Women diagnosed with unexplained infertility: normal ovulation (21‐ to 35‐day menstrual cycles with variation < 8 days and luteal phase progesterone test), normal semen analysis (progressive motility ≥ 32%, volume ≥ 1.5 mL, conc. ≥ 15 million/mL) or total motile count ≥ 10 million

  • Havin either (a) at 2 ovaries and 2 probably patent (functioning) fallopian tubes (confirmed by hysteroscopy or hysterosalpingography (HSG)) or (b) a previous intrauterine pregnancy, and no subsequent surgery or ectopic pregnancy that may reduce tubal patency or ovarian function

  • Body mass index ≤ 35 kg/m²

  • Negative cervical PAP smear within the last 3 years

  • Willing to have regular sexual intercourse following the procedure in the month of the procedure and for 2 months following the procedure (or until pregnancy occurs)


Exclusion criteria:
  • Having had any disruptive instrumentation within the uterine cavity (e.g. hysteroscopy, HSG, laparoscopy, surgically managed miscarriage, endometrial biopsy) within 3 months before Day 1 of the first study menstrual cycle, or planning to undergo a procedure involving disruptive instrumentation at any stage during the study

  • Entered previously into this study or participated in another trial in the last 30 days

  • Any contraindication to endometrial biopsy, or pregnant or carrying a pregnancy to term, or both

Interventions Intervention group: a single endometrial pipelle biopsy performed between Day 1 and 12 of a menstrual cycle
Control group: a single placebo procedure performed between Day 1 and 12 of a menstrual cycle
Outcomes Live birth, miscarriage, ongoing pregnancy, clinical pregnancy, multiple pregnancy, pain during the procedure, bleeding following the procedure
Starting date June 2014
Contact information Sarah Lensen; s.lensen@auckland.ac.nz
Notes ACTRN12614000656639
Confirmed as ongoing by author correspondence in July 2020